During studies demonstrating the multiplication of herpes simplex virus (HSV) in human leukocytes (Nahmias, Kibrick, and Rosan, J. Immunol. in press), it was noted that a constituent of the leukocyte cultures had an inhibitory effect on the virus. Experiments leading to the identification of this inhibitory substance as heparin will be presented. Also reported are studies which attempt to elucidate the active grouping on the heparin molecule responsible for its inhibitory property, and observations on the nature of the heparin-virus-cell interaction.
culture was found to be 1 to 2 units per ml (10 to 20 ,g/ml). This effect was confirmed with other strains of herpes simplex virus, other tissueculture systems, and other media. The inhibitory activity of the heparin was found to be related to the sulfate groupings on the molecule. The effect of heparin appears to be on the virus, rather than on the cell. The virus is not inactivated, however, and the heparin-virus "complex" is readily dissociable on dilution. Heparin was shown to affect viral infection in its earliest phase, probably at the primary electrostatic attachment of virus to cell. The import of these and related observations on common virological laboratory procedures and the possible biological significance of our findings are discussed.
During studies demonstrating the multiplication of herpes simplex virus (HSV) in human leukocytes (Nahmias, Kibrick, and Rosan, J. Immunol. in press), it was noted that a constituent of the leukocyte cultures had an inhibitory effect on the virus. Experiments leading to the identification of this inhibitory substance as heparin will be presented. Also reported are studies which attempt to elucidate the active grouping on the heparin molecule responsible for its inhibitory property, and observations on the nature of the heparin-virus-cell interaction. 
MATERIALS AND METHODS
Leukocyte and control cultuires. Leukocyte cultures were prepared from heparinized blood (50 units of heparin per ml) by the method of Moorhead et al. (1960) . This blood was obtained from donors lacking neutralizing antibodies to HSV. Control plasma cultures were prepared with the same constituents, except that 1 ml of the donor's plasma was used instead of the leukocyte-plasma suspension.
Viruses tested. Most of the experimental work was done with a laboratory strain of HSV (Rodanus) which had undergone multiple passages in eggs and primary human amnion tissue cultures. Two other laboratory strains with similar passage histories (Zaccardi and Virtue), the proliferating and giant cell strains of HSV (Scott, McLeod, and Tokumaru, 1961) , and four recent isolates from human herpetic infections of skin and cornea were also tested.
Tissue culture and media. Primary human amnion cell cultures were prepared and maintained with bovine amniotic fluid media (Milovanovic, Enders, and Mitus, 1957) . For certain experiments, minimal essential medium (MEM) (Eagle, 1959) delay of CPE in the 10-1 dilution, as compared with the 10-2 dilution, was observed on the second titration day. Because it had previously been reported (Gresser, 1961 ) that leukocytes exposed to certain viruses could produce interferon, the possibility that interferon was responsible for this effect was first considered. The presence of a similar inhibitory effect in the undiluted specimens of the plasma control series, however, refuted this hypothesis (Table 1-B) .
The possibility was then investigated that some plasma component not present in serum (e.g., fibrinogen) was responsible for this inhibition. The initial experiments on this point appeared to support this view, because they revealed that the heparinized plasma, but not serum, was inhibitory to HSV. When plasma prepared from the same donor by defibrination or by use of ethylenediaminetetraacetate (EDTA) or citrate as anticoagulants was tested, it was found to lack the inhibitory effect. These data suggested that heparin was the inhibitory substance.
Titration of heparin inhibitory effect. With the procedure described under Materials and Meth- Consistency of heparin inhibitory effect on various strains of HSV and with different tissueculture systems and media. Four recent isolates from human infections with HSV, when tested at a dose of 100 TCD5o with varying heparin concentrations, were also found to be inhibited by 5 to 10 units per ml of heparin (initial concentration). In addition, three laboratory strains and the proliferative and giant cell variants of HSV were inhibited by similar concentrations. Testing of the Rodanus strain in hamster kidney, rabbit kidney, and diploid (MA 10) cultures revealed inhibition of virus by heparin at similar concentrations in these tissue-culture systems. This was also the case when Eagle's MEM with 10% calf serum was substituted for the bovine amniotic fluid medium.
Verification that the inhibitory effect is due to heparin. Because heparin is a biological rather than a synthetic product, the possibility was examined that impurities in the preparation, rather than heparin, were responsible for the inhibitory effect. Table 3 presents results of tests evaluating the inhibitory activity of six biological heparin preparations. These materials, supplied by three different companies, had been prepared from three different body sources of pork and beef. The activity of these preparations in units per milligram, as reported by the manufacturer, is recorded in Table 3 , as is the minimal inhibitory concentration of the preparation in the initial heparin-virus mixture. It is apparent that all six products had very similar end points. Although this evidence did not completely rule out the possible existence of a common impurity in the six preparations of varied origin, this possibility was held as unlikely.
Correlation of inhibitory activity with sulfate groupings on heparin molecule. Because heparin is a sulfated mucopolysaccharide whose sulfate groupings are believed to be closely associated with its anticoagulating property, it was considered of interest to determine whether neutralization of sulfate groups with protamine would affect the virus-inhibition capacity. The effect of protamine neutralization on blood-clotting time was also determined.
As the concentration of protamine was decreased, thus increasing the number of available sulfate groups on the heparin molecules, there was a close parallel between the curves for viral CPE and blood-clotting inhibition (Fig. 1) . When 1.0 mg or less of protamine was added to 2 mg of heparin, enough sulfate groups were left unneutralized to inhibit completely further viral CPE and blood clotting.
Results of tests for virus-inhibitory activity with synthetic polymers of varying degrees of sulfation (to be reported) afforded further support for the importance of the sulfate group in this inhibitory activity.
Observations on the nature of the heparin-viruscell interaction: effect on cell of pretreatment with heparin. Human amnion tissue cultures were Table 5 presents results obtained when amnion tubes inoculated with 1,000 TCD50 of virus were then exposed to 20 units per ml of heparin at various time intervals ranging up to 10 hr after viral inoculation. Complete inhibition of CPE was found to occur only when heparin was added at 0 hr. Up to 1 hr, there was some delay in the appearance of CPE. Subsequently, CPE appeared at the same time in tissue-culture tubes both with and without heparin. These results suggest that the heparin effect occurs very early in the viral infectious cycle, probably at the first phase of adsorption during the initial ionic at- (Cohen, 1942; Heyman et al., 1958; Young and Mora, 1960; Vaheri and Pentinnen, 1962; Feltz and Regelson, 1962) reported on the effect of various polyanions on certain bacterial, plant, animal, and human viruses, heparin presents certain features of particular biological import as regards viruses affecting man. Heparin is present in various animal and human tissues (Riley, 1963) (Riley, 1963) , forms a complex with susceptible viruses, localizing them to their site of infection and thus limiting their spread. Our in vitro data demonstrating that high viral concentrations can escape the heparin effect would provide a possible in vivo limitation to this protective mechanism, were it to be actually operative. These results with heparin and HSV are analogous to those obtained by Roizman and Roane (1963) with antiserum and HSV, whereby, with the use of large viral inocula, a small fraction of virus was found to resist neutralization by all dilutions of antiserum.
Many explanations have been offered for the ability of herpes simplex virus to remain latent and produce recurrent lesions in spite of the presence of circulating antibodies (Glasgow and Habel, 1963) . Since in vitro experiments revealed that heparin and other polyanions exert an inhibitory but reversible effect on the infectivity of the virus, the possibility may be considered that such an effect may also occur in vivo. Under certain stimuli (e.g., fever and stress), infective virus may become dissociated from a polyanion complex, thus permitting its local proliferation, with further spread prevented by the presence of circulating antibodies.
The inhibitory action of heparin and other polyanions has practical significance in several procedures commonly employed by virologists. Because herpes simplex and certain other viruses are inhibited by these compounds, attempts to recover such agents from heparinized blood (e.g., Geller, Coleman, and Jawetz, 1953) would probably fail. We have, in fact, found no record of isolation of HSV from heparinized blood. On the other hand, two successful recoveries of this agent from the blood of patients were made from specimens of clotted blood (Ruchman and Dodd, 1950; McKenzie, 1961, personal communication) . In this regard, it should be noted that plasma prepared with EDTA or citrate had no inhibitory effect on HSV.
Although the amount of heparin employed for preparation of plasma clot tissue cultures is usually very small, it might still interfere with the growth of particularly susceptible viruses. Indeed, the "other factor" which Scott et al. (1953) found to cause nonspecific adsorption of HSV to plasma clot cultures might well have been heparmn.
An inhibitory effect of acid mucopolysaccharides present in agar used as overlay in the plaquing of a number of viruses was reported recently by several workers Liebhaber, 1961, 1962; Liebhaber and Takemoto, 1961; Schulze and Schlesinger, 1963; Col6n, Idoine, and Brand, 1963) . With regard to HSV, Tytell and Neuman (1963) (Roizman and Roane, 1963) which also have differing cytopathic manifestations in tissue culture.
The observations obtained to date on the nature of the heparin-virus-cell interaction suggest that heparin and other sulfated polyanions tested inhibit susceptible viruses by the strongly anionic charge provided by their sulfate groups. Heparin seems to affect the virus at its earliest infective stage, and the heparin-virus "complex" formed is readily reversible, at least on dilution. It would appear from these findings that we are dealing with an effect at the primary attachment level (Tolmach, 1957 (Col6n et al., 1963) would also suggest that the site of action of these polyanionic compounds is at this level.
Based on the assumption that we are dealing with an ionic effect on cell and virus surface, the relative susceptibility of viruses to heparin may offer a clue as to the surface charge on virus particles. Such information is now lacking for most mammalian viruses (Brinton and Lauffer, 1959 
